Wei, Jing https://orcid.org/0009-0003-7362-7162
Wang, Jing https://orcid.org/0000-0003-4331-6243
Guan, Wen https://orcid.org/0000-0001-7349-0555
Li, Jingjing
Pu, Tianjie https://orcid.org/0000-0001-6452-3650
Corey, Eva https://orcid.org/0000-0002-9244-3807
Lin, Tzu-Ping
Gao, Allen C
Wu, Boyang Jason https://orcid.org/0000-0002-2823-3573
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-19-1-0279)
U.S. Department of Defense (W81XWH-14-2-0183)
U.S. Department of Defense (W81XWH-18-2-0013)
U.S. Department of Defense (W81XWH-18-2-0015)
U.S. Department of Defense (W81XWH-18-2-0016)
U.S. Department of Defense (W81XWH-18-2-0017)
U.S. Department of Defense (W81XWH-18-2-0018)
U.S. Department of Defense (W81XWH-18-2-0019)
HHS | National Institutes of Health (R37CA233658)
HHS | National Institutes of Health (R01CA258634)
HHS | National Institutes of Health (P50CA097186)
HHS | National Institutes of Health (P01CA163227)
HHS | National Institutes of Health (R01CA279528)
Washington State University (WSU startup funds)
Article History
Received: 9 April 2024
Revised: 6 December 2024
Accepted: 11 December 2024
First Online: 2 January 2025
Disclosure and competing interests statement
: EC received sponsored research funding from Sanofi, Gilead, AbbVie, Genentech, Janssen Research, Astra Zeneca, GSK, Bayer Pharmaceuticals, Forma Pharmaceuticals, Foghorn, Kronos, and MacroGenis. The other authors declare no competing interests.